CureusJune 18, 2021Katelyn Grechuk, Heela Azizi, Vatsala Sharma et al.
The question of whether cannabis can trigger schizophrenia continues to be a subject of interest. There has been an increasing focus on identifying potential genetic factors that may predispose cannabis users to develop schizophrenia. One such gene identified in many studies codes for a catechol-O-methyltransferase (COMT) enzyme polymorphism. These studies, however, are limited by the inclusion...
Background: 3,4-methylenedioxymethamphetamine (MDMA), known recreationally as "Molly" or "Ecstasy", is a triple monoamine reuptake inhibitor. MDMA specifically acts as a weak 5-HT1 and 5-HT2 receptor agonist, targeting 5-HT2A, 5-HT2B, and 5-HT2C receptors. Its potential use for therapeutic purposes with these pharmacological profiles remains a controversial subject. Studies have shown the...
The Spectrum of Dissociative Disorders are based on criteria that define the dissociative experience of depersonalization along the spatial dimension with patients having dissociative episodes typically describe the experience of being spatially removed from the first person experience. We present the unique case of a patient with Other Specified Dissociative Disorder who exhibits...